Skip to Content

'
Mimi I. Hu, M.D.

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX

Clinical Interests

Thyroid cancer
Multiple endocrine neoplasia, Types 1 and 2
Bone and mineral metabolism disorders
Parathyroid disorders
Pituitary tumors
Endocrine sequelae of cancer and its therapies

Education & Training

Degree-Granting Education

2000 University of Texas Houston Health Science Center, Houston, TX, MD, Medicine
1993 Rice University, Houston, TX, BS, Mechanical Engineering

Postgraduate Training

8/2005-7/2010 Clinical Research, Curriculum, Center for Clinical Research and Evidence-Based Medicine, University of Texas-Houston Medical School, Houston, TX, Kathleen Kennedy, MD
7/2004-6/2007 Clinical Fellowship, Endocrinology, Baylor College of Medicine, Houston, TX, Ashok Balasubramanyam
7/2001-6/2003 Clinical Residency, Internal Medicine, Baylor College of Medicine, Houston, TX, Amir Halevy
6/2000-6/2001 Clinical Internship, Internal Medicine, Baylor College of Medicine, Houston, TX, Amir Halevy

Board Certifications

2006 Endocrinology, Diabetes and Metabolism
2004 Internal Medicine

Experience/Service

Academic Appointments

Chief Medical Resident, Division of Internal Medicine, Baylor College of Medicine, Houston, TX, 7/2003-6/2004

Administrative Appointments/Responsibilities

Member-Endocrine Center Steering Committee for the Institute of Personalized Cancer Therapy, Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 10/2008-present
Member-Thyroid Cancer Survivorship Program, Department of Endocrine Neoplasia and Hormonal Disorders, Thyroid Cancer Survivorship Program, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 2008-present

Honors and Awards

2006 Travel Grant Award for Young Investigators, American Thyroid Association 77th Annual Meeting
1999 Alpha Omega Alpha Honor Society

Professional Memberships

American Association of Clinical Endocrinologists
Member, 2005-present
American College of Physicians
Member, 2000-present
American Medical Association
Member, 1996-present
American Society for Bone and Mineral Research
Member, 2007-present
American Society of Clinical Oncology
Member, 2007-present
American Thyroid Association
Member, 2006-present
ASBMR Women in Bone and Mineral Research Committee
Council Member, 2008-2011
Endocrine Society
Member, 2006-present

Selected Publications

Peer-Reviewed Original Research Articles
1. Stava CJ, Jimenez C, Hu MI, Vassilopoulou-Sellin R. Skeletal sequelae of cancer and cancer treatment. J Cancer Surviv 3(2). e-Pub 5/2009. PMID: 19412668.
2. Grubbs EG, Rich TA, Li G, Sturgis EM, Younes MN, Myers JN, Edeiken-Monroe B, Fornage BD, Monroe DP, Staerkel GA, Williams MD, Waguespack SG, Hu MI, Cote G, Gagel RF, Cohen J, Weber RS, Anaya DA, Holsinger FC, Perrier ND, Clayman GL, Evans DB. Recent advances in thyroid cancer. Curr Probl Surg 45(3):156-250, 3/2008. PMID: 18346477.
3. Hoff AO, Toth BB, Altundag K, Johnson MM, Warneke CL, Hu M, Nooka A, Sayegh G, Guarneri V, Desrouleaux K, Cui J, Adamus A, Gagel RF, Hortobagyi GN. Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. J Bone Miner Res 23(6):826-36, 2008. PMCID: PMC2677083.

Invited Articles
1. Jiménez C, Hu MI, Gagel RF. Management of medullary thyroid carcinoma. Endocrinol Metab Clin North Am 37(2):481-96, 2008. PMID: 18502338.
2. Hu MI. Medical management of medullary thyroid carcinoma. Department of Endocrine Neoplasia and Hormonal Disorders Newsletter 1(2), 2008.
3. Hu MI, Cote G, Gagel RF. RET gene: a therapeutic target in medullary thyroid carcinoma. Current Problems in Surgery 45(3):156-250, 2008.
4. Hu MI, Gagel RF, Jimenez C. Bone loss in patients with breast or prostate cancer. Curr Osteoporos Rep 5(4):170-8, 2007. PMID: 18430392.
Other Articles
1. Hu MI, Hoff AO, Gagel RF. Short-term teriparatide in the treatment of postoperative hypocalcemia. EndoTrends 14(1):4-5, 2007.

Book Chapters
1. Hu M, Gagel RF. Multiple Endocrine Neoplasia Type 2. In: Endocrinology, 6th edition. Ed(s) LJ DeGroot, JL Jameson. Saunders. In Press.
2. Hu MI, Sherman SI. Endocrine complications of head and neck surgery. In: Complications in Head and Neck Surgery, 2nd edition. Ed(s) Eisele, DW, 2009.
3. Hu MI, Yeung SJ, Gagel RF. Endocrine paraneoplastic syndromes. In: Internal Medicine Care of Cancer Patients. Ed(s) Escalante C, Yeung J, Gagel RF. BC Decker Inc; the Holland-Frei Series: Ontario, 2009.
4. Hu MI, Vassilopoulous-Sellin R, Lustig R, Lamont J. Thyroid and Parathyroid Cancers. In: Cancer Management: A Multidisciplinary Approach, 11th Edition. CMPMedica, 2009.
5. Hu MI, Gagel RF. Calcitonin Gene Family of Peptides. In: Principles of Bone Biology, 3rd edition. Ed(s) Bilezikian J, Raisz L, Rodan G, 2008.
 

Other
1. Patient Education Pamphlet.

Osteoporosis. Bone Disease Program of Texas, University of Texas M.D. Anderson Cancer Center, Houston, Texas, 2006

.
2. Patient Education On-line Materials.

Multiple Endocrine Neoplasia. Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas M.D. Anderson Cancer Center, Houston, Texas, 2006

.
3. Patient Education On-line Materials.

Medullary Thyroid Carcinoma. Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas M.D. Anderson Cancer Center, Houston, Texas, 2007

.

Last updated: 9/21/2009